Analysis of regulatory T lymphocytes in patients with traumatic brain injury

封面

如何引用文章

全文:

详细

In recent years, traumatic brain injury (TBI) has been one of the most urgent medical and social problems due to its prevalence, predominantly affecting young people of working age, causing high mortality, disability and economic costs for treatment and subsequent rehabilitation of patients. At present, the role of patients’ immune system in evolving neuroinflammation after traumatic brain injury has been proven. Treg cell populations represent an important factor determining the outcome of the disease due to promoting induction of immunological tolerance, being a significant component of immunoregulation. As a result of our study, we found a decrease in the relative content of Treg within the total lymphocyte pool of peripheral blood, which has the CD3+CD4+CD25bright phenotype in patients of the 3rd and 4th groups, in comparison with the data from control group. Moreover, a decreased relative content of Tregs (CD4+CD25+T cells) was revealed which is due to the degree of brain tissue damage and, as a result, their migration to suppress inflammation due to production of anti-inflammatory cytokines (TGF-â, IL-10). The Treg population is heterogeneous, thus prompting us for analysis of the Treg subpopulations profile based on the expression of CD45R0 and CD62L. When assessing subpopulations of regulatory T lymphocytes within CD45Ro and CD62L, significant changes were found only in patients with brain contusion. The changes were revealed within the pool of “naive” T regulatory lymphocytes with the CD3+CD4+CD25brightCD39+ Treg phenotype, capable of producing a wide range of cytokines specific for Th1, Th2, Th17, in patients with mild, moderate and severe TBI. Meanwhile, the level of highly active CD3+CD4+CD25brightCD73+ Tregs was significantly reduced in patients with moderate and severe TBI. These changes indicate an imbalance in immunoregulatory processes resulting from extensive damage to brain tissues.

作者简介

Anna Norka

First St. Petersburg State I. Pavlov Medical University; Saint Petersburg Pasteur Institute

Email: norka-anna@mail.ru

Senior Laboratory Assistant, Department of Immunology, First St. Petersburg State I. Pavlov Medical University; Neurologist, Medical Centre, St. Petersburg Pasteur Research Institute of Epidemiology and Microbiology

俄罗斯联邦, St. Petersburg; St. Petersburg

S. Vorobyev

V. Almazov National Medical Research Centre

Email: norka-anna@mail.ru

PhD, MD (Medicine), Chief Research Associate, Research Laboratory of Neurology and Neurorehabilitation, V. Almazov National Medical Research Centre

俄罗斯联邦, St. Petersburg

R. Kuznetsova

First St. Petersburg State I. Pavlov Medical University; Saint Petersburg Pasteur Institute

Email: norka-anna@mail.ru

PhD (Medicine), Associate Professor, Department of Immunology, First St. Petersburg State I. Pavlov Medical University; Allergist-Immunologist, Medical Centre, St. Petersburg Pasteur Research Institute of Epidemiology and Microbiology

俄罗斯联邦, St. Petersburg; St. Petersburg

M. Serebriakova

S. Kirov Military Medical Academy

Email: norka-anna@mail.ru

Postgraduate Student, Research Associate, Department of Immunology, Institute of Experimental Medicine

俄罗斯联邦, St. Petersburg

I. Kudryavtsev

First St. Petersburg State I. Pavlov Medical University; Institute of Experimental Medicine

编辑信件的主要联系方式.
Email: norka-anna@mail.ru

PhD (Biology), Senior Research Associate, Department of Immunology, Institute of Experimental Medicine; Associate Professor, Department of Immunology, First St. Petersburg State I. Pavlov Medical University

俄罗斯联邦, St. Petersburg; St. Petersburg

S. Kovalenko

S. Kirov Military Medical Academy

Email: norka-anna@mail.ru

Lecturer, Department of Neurosurgery, S. Kirov Military Medical Academy

俄罗斯联邦, St. Petersburg

D. Monashenko

St. Petersburg City Hospital No. 26, St. Petersburg

Email: norka-anna@mail.ru

PhD (Medicine), Neurosurgeon, St. Petersburg City Hospital No. 26

俄罗斯联邦, St. Petersburg

参考

  1. Байдун Л.А., Зурочка А.В., Хайдуков С.В., Тотолян Арег А. Стандартизованная технология «Исследование субпопуляционного состава лимфоцитов периферической крови с применением проточных цитофлюориметров-анализаторов» (проект) // Медицинская иммунология, 2012. Т. 14, № 3. С. 255-268. [Baidun L.A., Zurochka A.V., Khaidukov S.V., Totolian Areg A. Methods. Standardized technology “Study of the subpopulation composition of peripheral blood lymphocytes using flow cytofluorometer-analyzers” (draft). Meditsinskaya immunologiya = Medical Immunology (Russia), 2012, Vol. 14, no. 3. pp. 255-268. (In Russ.)] doi: 10.15789/1563-0625-2012-3-255-268.
  2. Кудрявцев И.В., Субботовская А.И. Опыт измерения параметров иммунного статуса с использованием шестицветного цитофлуоримерического анализа // Медицинская иммунология, 2015. T. 17, № 1. С. 19-26. [Kudryavtsev I. V., Subbotovskaya A.I. Application of six-color flow cytometric analysis for immune profile monitoring. Meditsinskaya immunologiya = Medical Immunology (Russia), 2015, Vol. 17, no. 1, pp. 19-26. (In Russ.)] doi: 10.15789/1563-0625-2015-1-19-26.
  3. Лихтерман Л.Б. Черепно-мозговая травма. Диагностика и лечение. М.: ГЭОТАР-Медиа, 2014. 488 с. [Likhterman L.B. Traumatic brain injury. Diagnosis and treatment]. Moscow. GEOTAR-Media, 2014. 488 pp.
  4. Сабиров Д.М., Росстальная А.Л., Махмудов М.А. Эпидемиологические особенности черепно-мозгового травматизма // Вестник экстренной медицины, 2019. № 2. С. 61-65. [Sabirov D.M., Rosstalnaya A.L., Makhmudov M.A. Epidemiological features of craniocerebral traumatism. Vestnik ekstrennoy meditsiny = Bulletin of Emergency Medicine, 2019, no. 2, pp. 61-65. (In Russ.)]
  5. Dantzer R., O’Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci., 2008, Vol. 9. no. 1, pp. 46-56. doi: 10.1038/nrn2297.
  6. Erickson M.A., Wilson M.L. In vitro modeling of blood-brain barrier and interface functions in neuroimmune communication. Fluids Barriers CNS, 2020, Vol. 17, no. 1, 26. doi: 10.1186/s12987-020-00187-3.
  7. Langeh U.U., Singh S. Targeting S100B protein as a surrogate biomarker and its role in various neurological disorders. Curr. Neuropharmacol., 2021, Vol. 9, no. 2, pp. 265-277.
  8. Nizamutdinov D., Shapiro L.A. Overview of traumatic brain injury: an immunological context overview of traumatic brain injury: an immunological context. Brain Sci., 2017, Vol. 7, no. 1, 11. doi: 10.3390/brainsci7010011.
  9. Peeters W.R., van den Brande R., Polinder S. Epidemiology of traumatic brain injury in Europe. Acta Neurochir. (Wien), 2015, Vol. 157, no. 10, pp. 1683-1696.

版权所有 © Норка А., Воробьев С., Кузнецова Р., Серебрякова М., Кудрявцев И., Коваленко С., Монашенко Д., 2023

Creative Commons License
此作品已接受知识共享署名 4.0国际许可协议的许可
##common.cookie##